This article relies largely or entirely on a single source. (November 2024) |
ARM390 is an opioid-analgesic compound selective for the delta opioid receptor. In contrast to the delta-opioid selective agonist SNC-80, ARM390 was not found to produce receptor desensitization following multiple administrations. Although behavioral desensitization formed to the analgesic effect of ARM390 through a receptor internalization-independent mechanism, anxiolytic effects persisted during long-term treatment.[1] ARM390 has been dubbed a "low-internalizing agonist" of delta opioid receptors.[1]
Names | |
---|---|
IUPAC name
N,N-diethyl-4-[phenyl(piperidin-4-ylidene)methyl]benzamide
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
| |
| |
Properties | |
C23H28N2O | |
Molar mass | 348.490 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
References
edit- ^ a b Pradhan, Amynah A.; Befort, Katia; Nozaki, Chihiro; Gavériaux-Ruff, Claire; Kieffer, Brigitte L. (October 2011). "The delta opioid receptor: an evolving target for the treatment of brain disorders". Trends in Pharmacological Sciences. 32 (10): 581–590. doi:10.1016/j.tips.2011.06.008. PMC 3197801. PMID 21925742.